Skip over main navigation
  • Log in
  • Basket: (0 items)
Neuroblastoma Australia
Newsletter sign up
  • Twitter
  • Facebook
  • YouTube
  • instagram
  • LinkedIn
Charity Shop Donate
  • Twitter
Menu
  • About Neuroblastoma
    • What is neuroblastoma?
      • What is neuroblastoma?
      • Neuroblastoma Fact Sheet
      • Resources
      • Coronavirus help guide
    • Family stories
    • Key research areas
  • About Us
    • Our purpose
    • Our story
    • Our people
      • Our Board
      • Our Scientific Advisory Board
      • Our Neuroblastoma Australia Team
    • Our supporters
    • Our finances
    • News
    • Contact us
  • Family Support
    • Latest Health Advisory
    • Newly diagnosed
      • Key statistics
      • Causes & risks
      • Detection, diagnosis & staging
    • On treatment
      • Treatments & side effects
      • Clinical trials
      • Hospital tips
      • Life outside of hospital
      • Related Support Services
    • Post treatment
      • After treatment
      • Late effects
      • Relapse
    • Connecting with others
      • Family support group
      • Bereavement Support
      • Free family activities
    • Apply for an activity pack
  • Our Impact
    • Why fund research?
    • Our research projects
      • Current projects
      • Past projects
      • Grant recipients
    • Grant applications
  • Fundraise
    • Fundraise for us
    • Fundraising ideas
    • Support our fundraisers
      • All our fundraisers
      • Run2Cure Local
      • #44kmfor44kids
      • 2 Many 2 Young
    • Corporate fundraising
      • Workplace giving
      • Move2Cure
  • Events
    • Our neuroblastoma events
    • Other events
    • Past events
    • Conferences
    • Volunteer
  • Donate
    • Donate today
    • Give monthly
    • Support our appeals
    • In Memory of
    • Leave a gift in your will
  • Admin
    • Log in
  • Basket: (0 items)
  • COVID-19 vaccines for children aged 6 months to under 5 years
  1. Family Support

COVID-19 vaccines for children aged 6 months to under 5 years

ATAGI recommends COVID-19 vaccination for children aged 6 months to under 5 years in certain at-risk population groups. ATAGI has recommended the Moderna COVID-19 vaccine for children aged 6 months to under 5 years who are severely immunocompromised, or have disability, as well as those who have complex and/or multiple health conditions that increase their risk of severe COVID-19.

These include children with the following or similar conditions:

  • Severe primary or secondary immunodeficiency, including those undergoing treatment for cancer, or on immunosuppressive treatments as listed in the ATAGI advice on 3rd primary doses of COVID-19 vaccine in individuals who are severely immunocompromised;
  • Bone marrow or stem cell transplant, or chimeric antigen T-cell (CAR-T) therapy;
    Complex congenital cardiac disease;
  • Structural airway anomalies or chronic lung disease;
  • Type 1 diabetes mellitus;
  • Chronic neurological or neuromuscular conditions; or
  • A disability that requires frequent assistance with activities of daily living, such as severe cerebral palsy or Down Syndrome (Trisomy 21).

Read the full ATAGI statement on vaccination for children aged 6 months to under 5 years here.

These children will be able to receive a COVID-19 vaccination from Monday, 5 September.

As a peak body and advocacy organisation for health conditions impacting young Australian children, we are reaching out to provide you with resource materials to help you communicate with stakeholders about COVID-19 vaccines for vulnerable children and the general steps everyone, including children who are not eligible for a vaccine, can take to protect themselves from viral infections.

Please see attached the materials for your use:

• Teeny Tiny Stevies Childhood Immunisation Community Kit
• 6 months to under 5 years old Vaccine Eligibility flyer
• How to Speak to Kids About COVID-19 Vaccines fact sheet

For more information please see visit the Department of Health website.

Vaccination sites for children can be found on the Vaccine Clinic Finder with bookings now open.

Published: 13th September, 2022

Author: Payal Sangwan

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Nita Arora-Parkes

    Nita Arora-Parkes

    Nita is founder and Director of Groupcpo; a platform for small businesses and start-ups to find, buy and sell the tools and services they need to grow and scale their business. Nita has over 20 years’ experience as a technology and procurement executive, managing strategic partnerships and vendor negotiations with a global team.

  • Artist generously supports Neuroblastoma Australia

    Artist generously supports Neuroblastoma Australia

    Artist Craig Waddell has donated another stunning frangipani inspired art work to form the design for a 2nd limited edition tote bag.

  • 2022 Grant Round Announcement

    2022 Grant Round Announcement

    We are excited to announce the winners of our 2022 grants round. Two exceptional scientists will lead studies to develop tailored treatments to improve outcomes for children with neuroblastoma.

  • Nanoparticle therapy study

    Nanoparticle therapy study

    Recipient : Professor Maria Kavallaris
    Institute: Children's Cancer Institute
    Funding: $175,000 from 2023 to 2024

Most read

  • Emeline's Story

    Emeline's Story

    After months of misdiagnoses, including a middle-of-the-night emergency trip to the hospital, Emeline’s mum took her to a paediatric gastroenterologist believing her tummy issue was severe constipation. It turned out to be neuroblastoma.

  • What is neuroblastoma?

  • Run2Cure Local 2022

    Run2Cure Local 2022

    This September, Childhood Cancer Awareness Month join Run2Cure Local 2022. Run, get fit and fundraise at a location near you!

  • Detection, diagnosis & staging

    Detection, diagnosis & staging

    Know about symptoms of neuroblastoma, detection, diagnosis and different stages of neuroblastoma childhood cancer.

  • How common is neuroblastoma?

  • Donate today

    Donate today

    Help us beat the number one toddler cancer. Please donate today to support world class Australian research into developing better, safer treatments with the ultimate goal of finding a definitive cure for all children diagnosed with neuroblastoma.

  • Jazmyn's 2 many 2 young Walk

    Jazmyn's 2 many 2 young Walk

    Support this special 2.2 km walk - inspired by Jazmyn Mitchell. Dress Up and wear a tutu 2 help raise awareness on 20.02.2022 and support all the children affected by neuroblastoma. This is Jazmyn's walk and legacy - a special light in this world.

  • How dangerous is neuroblastoma?

  • Why does this cancer form?

  • Contact us

    Neuroblastoma Australia is a Sydney Children's Cancer Charity in Crows Nest and is a registered charity with GDR Status. The best way to contact us is through [email protected]

Tag cloud

#GivingTuesdayNow #run2curelocal 2little 44kmfor44kids A gift for a child with cancer Donate today Golf2Cure research Zach's neuroblastoma story

Latest tweet

  • #neuroblastomaawarenessweek #neuroblastoma #neuroblastomaaustralia https://t.co/yw83lFmhhM

    3rdFebruary, 2023 @NeuroblastomaAu
  • Today is #neuroblastomaawarenessday. Post a photo of a frangipani to raise awareness about this terrible childhood… https://t.co/JMK5Z4qPzp

    1stFebruary, 2023 @NeuroblastomaAu
  • One of the highlights of running the charity, Neuroblastoma Australia has been establishing an outstanding Scienti… https://t.co/R2OvK0aGdH

    28thDecember, 2022 @NeuroblastomaAu

Some of our generous supporters include:

  


 




Approved by:

 Social Impact 2020 Rating

  • Contact us
  • Media
  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Registered charity ABN : 74 173 375 414
Neuroblastoma Australia Level 1, 441 Pacific Highway, Crows Nest, NSW 2065,
+61 (0)2 9906 2066, [email protected]